FDA Adverse Event Injury Summary report: N

GORE EXCLUDER AAA ENDOPROTHESIS

MDR report key: 3122507 · Received May 15, 2013

Report

Report Number
2017233-2013-00306
Event Type
Injury
Date Received
May 15, 2013
Date of Event
March 18, 2013
Report Date
April 18, 2013
Manufacturer
W.L. GORE & ASSOCIATES,INC
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL EXCLUDER DEVICES INCLUDED IN THIS REPORT: PXC181000/7092814, PXA280300/7075028, PXC121000/06807946, PXA280300/7075029. RESULTS - A REVIEW OF THE MANUFACTURING RECORDS FOR THE DEVICES VERIFIED THAT THE LOTS MET ALL PRE-RELEASE SPECIFICATIONS. CONCLUSIONS - ACCORDING TO THE GORE EXCLUDER AAA ENDOPROSTHESIS INSTRUCTIONS FOR USE (IFU), USERS ARE MADE AWARE OF THE RISKS ASSOCIATED WITH TYPE II ENDOLEAKS AND ARE INSTRUCTED TO CONSIDER THE RISKS AND BENEFITS DISCUSSED IN THE IFU FOR EACH PATIENT BEFORE USING THE DEVICES. SPECIFICALLY, THE IFU WARNS THAT ADVERSE EVENTS THAT MAY OCCUR AND/OR REQUIRE INTERVENTION INCLUDE, BUT ARE NOT LIMITED TO ENDOLEAK AND ANEURYSM ENLARGEMENT.

Description of Event or Problem · 1

ON (B)(6) 2010, THE PATIENT WAS IMPLANTED WITH A SYSTEM OF GORE EXCLUDER AAA ENDOPROSTHESES TO TREAT AN ABDOMINAL AORTIC ANEURYSM. ON (B)(6) 2012, FOLLOW-UP COMPUTED TOMOGRAPHY (CT) SCAN REVEALED WHAT WAS THOUGHT TO BE A PROXIMAL TYPE I ENDOLEAK. THE PATIENT'S ANEURYSM MEASURED 6.2 X 6.1 CM IN DIAMETER. ON (B)(6) 2013, CT SCAN REVEALED THE SAME ENDOLEAK, WITH THE ANEURYSM MEASURING 6.8 X 6.4 CM IN DIAMETER. ON (B)(6) 2013, AN ANGIOGRAM CONFIRMED A TYPE II ENDOLEAK CONTRIBUTING TO ANEURISMAL ENLARGEMENT. THE PHYSICIAN WILL CONTINUE TO MONITOR THE PATIENT, AND DECIDE WHETHER RE-INTERVENTION WILL BE NECESSARY AT A LATER DATE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
215299 GORE EXCLUDER AAA ENDOPROTHESIS MIH/SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W.L. GORE & ASSOCIATES,INC 7193597

Patients

Seq Age Sex Outcome Treatment
1 75 YR Other ATORVASTATIN| METOPROLOL| MELOXICAM